A Neurobiological Hypothesis of Treatment-Resistant Depression – Mechanisms for Selective Serotonin Reuptake Inhibitor Non-Efficacy
First-line treatment of major depression includes administration of a selective serotonin reuptake inhibitor (SSRI), yet studies suggest that remission rates following two trials of an SSRI are less than 50%. The authors examine the putative biological substrates underlying Treatment Refractory Depr...
Main Authors: | Jeremy D Coplan, Srinath eGopinath, Chadi G Abdallah, Benjamin eBerry |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2014-05-01
|
Series: | Frontiers in Behavioral Neuroscience |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fnbeh.2014.00189/full |
Similar Items
-
Selective serotonin reuptake inhibitors (SSRIs) and breast cancer : a record linkage study
by: Ashbury, Janet E.
Published: (2008) -
Selective serotonin reuptake inhibitor (SSRI) antidepressants, prolactin and breast cancer
by: Janet eAshbury, et al.
Published: (2012-12-01) -
Acute Angle-Closure—A Rare but Vision-Threatening Ocular Adverse Effect of Selective Serotonin Reuptake Inhibitors
by: Michał Wiciński, et al.
Published: (2021-04-01) -
Differential Roles of the Two Raphe Nuclei in Amiable Social Behavior and Aggression – An Optogenetic Study
by: Diána Balázsfi, et al.
Published: (2018-08-01) -
Early effects of selective serotonin reuptake inhibitors (SSRIs) on cornea and lens density in patients with depression
by: Yalçın Karaküçük, et al.
Published: (2019-10-01)